Delivery Order SPE2DB20D3101-SPE2DB25FRSX4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for MYRBETRIQ ER 50 MG tablets (quantity: 90-count supply) with a ceiling value of $3,120.05 under a firm fixed price contract. This is a non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion potential value through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $20,957.72 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 mg tablets (90-count units). This competitive award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $6,227.41 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $7,794.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count unit). The contract utilizes firm fixed-price pricing with an ultimate completion date of July 29, 2025, and represents a non-competitive, non-set-aside award. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 25 mg tablets (90-count) valued at $5,569.27 under a firm fixed price contract. This award, issued on July 31, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ (mirabegron) is a beta-3 agonist medication used to treat...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The award, valued at $31,007.01, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations on this award. The company holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,109.65 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on August 11, 2025, with completion expected by August 12, 2025, this firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,013.94 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price contract utilized competitive procedures with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count quantity) valued at $7,075.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set to be completed by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSX4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,663.48 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 mg tablets (90-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The company maintains an extensive portfolio of federal contracts with DLA and the Defense Health Agency, supplying a broad range of pharmaceuticals including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery of MYRBETRIQ (mirabegron), a medication used to treat overactive bladder, supports the company's ongoing role in fulfilling federal medical supply needs for military and veteran healthcare systems. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/18/25 |